246 related articles for article (PubMed ID: 762425)
1. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
Kazatchkine MD; Fearon DT; Austen KF
J Immunol; 1979 Jan; 122(1):75-81. PubMed ID: 762425
[No Abstract] [Full Text] [Related]
2. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
Isenman DE; Podack ER; Cooper NR
J Immunol; 1980 Jan; 124(1):326-31. PubMed ID: 7350230
[TBL] [Abstract][Full Text] [Related]
3. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
[TBL] [Abstract][Full Text] [Related]
4. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
Moore FD; Fearon DT; Austen KF
J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
[No Abstract] [Full Text] [Related]
5. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
6. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
[No Abstract] [Full Text] [Related]
7. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
Fearon DT
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1971-5. PubMed ID: 273923
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
9. Effect of gangliosides on activation of the alternative pathway of human complement.
Michalek MT; Bremer EG; Mold C
J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
[TBL] [Abstract][Full Text] [Related]
10. Activation of the alternative pathway of complement by antiserum to factor B.
Wilson MR; Arroyave CM; Tan EM
J Lab Clin Med; 1979 Mar; 93(3):493-8. PubMed ID: 107255
[TBL] [Abstract][Full Text] [Related]
11. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
Pangburn MK; Morrison DC; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1980 Feb; 124(2):977-82. PubMed ID: 7356723
[No Abstract] [Full Text] [Related]
14. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
15. Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.
Kings M; Nydegger UE; de Weck AL
Immunology; 1984 Jan; 51(1):123-31. PubMed ID: 6197357
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
17. [Non-specific immune mechanisms. The alternate pathway in the complement system].
Schön K; Koeppe HW
Med Klin; 1979 Mar; 74(13):461-9. PubMed ID: 431472
[No Abstract] [Full Text] [Related]
18. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
19. Activation of human complement by heat-killed, human kidney cells grown in cell culture.
Baker PJ; Osofsky SG
J Immunol; 1980 Jan; 124(1):81-6. PubMed ID: 6765971
[No Abstract] [Full Text] [Related]
20. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
